We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
+22.91%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$777M
AUM Growth
+$118M
Cap. Flow
-$23.3M
Cap. Flow %
-3%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$1.5M

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$24.8M

Sector Composition

Rank Sector Weight
1 Healthcare 93.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$501M 64.5%
16,484,638
-932,100
-5% -$24.8M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$153M 19.68%
2,322,835
+27,900
+1% +$1.5M
ALKS icon
3
Alkermes
ALKS
$8.82B
$56.4M 7.26%
1,030,639
– –
CLDX icon
4
Celldex Therapeutics
CLDX
$2.77B
$17.9M 2.31%
420,847
– –
SPXU icon
5
ProShares UltraPro Short S&P 500
SPXU
$436M
$14M 1.8%
3,075
– –
SDS icon
6
ProShares UltraShort S&P500
SDS
$406M
$12.9M 1.66%
12,600
– –
EPI icon
7
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$11.1M 1.43%
400,000
– –
INDA icon
8
iShares MSCI India ETF
INDA
$6.71B
$10.5M 1.35%
290,000
– –

Similar funds

BHCM
Boulder Hill Capital Management New York $47.9M AUM
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BHH
Baker Hughes Holdings Houston, Texas $47.6M AUM 26.35% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Meditor Group's Q4 2017 Portfolio in Review

As of Q4 2017, Meditor Group held 8 positions worth $777M, up 18% from $659M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 0%. Meditor Group opened no new positions and made no exits, leaving the 8-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 92% a quarter earlier.

  • Meditor Group added most to Esperion Therapeutics in Q4 2017, an estimated $1.5M increase.
  • Meditor Group's biggest Q4 2017 reduction was Exelixis, cutting an estimated $24.8M.
  • Meditor Group's ten largest holdings make up 100% of its $777M portfolio in Q4 2017.
  • Meditor Group opened 0 new positions and closed 0 in Q4 2017.
  • Meditor Group's portfolio value rose 18% quarter-over-quarter to $777M.

Based on Meditor Group's 13F filing for Q4 2017, filed 3 Jan 2018.